Mylan's EpiPen Price Increases Highlight Its Grip on the Market

The ability of Mylan to raise EpiPen’s list price by nearly 550% over the past eight years underscores the pricing power drug companies enjoy for iconic brands facing little competition.

from WSJ.com: US Business http://ift.tt/2bjvyuY
via IFTTT